Secondary Logo

Journal Logo

August 2001 - Volume 24 - Issue 4
pp: 323-428

CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer: A Phase III Randomized Multicenter Study

Ron, Ilan G.; Wigler, Nely; Borovik, Riva; More

American Journal of Clinical Oncology. 24(4):323-327, August 2001.

Treatment of Aggressive Non-Hodgkin's Lymphoma in Elderly Patients With Thiotepa, Novantrone (Mitoxantrone), Vincristine, Prednisone (TNOP)

Lichtman, Stuart M.; Kolitz, Jonathan; Budman, Daniel R.; More

American Journal of Clinical Oncology. 24(4):360-362, August 2001.

Pharmacologic Study of Paclitaxel Administered With or Without the Cytoprotective Agent Amifostine, and Given as a Single Agent or in Combination With Epirubicin and Cisplatin in Patients With Advanced Solid Tumors

Van den Brande, Jan; Panday, Vinodh R. Nannan; Hoekman, Klaas; More

American Journal of Clinical Oncology. 24(4):401-403, August 2001.

A Dose-Finding Study of the Weekly Administration of Paclitaxel in Patients With Advanced Solid Tumors

Kouroussis, Charalambos; Kakolyris, Stelios; Mavroudis, Dimitris; More

American Journal of Clinical Oncology. 24(4):404-407, August 2001.

Show: